Mesothelin, Stereocilin, and Otoancorin are predicted to have superhelical structures with ARM-type repeats - PubMed (original) (raw)
Mesothelin, Stereocilin, and Otoancorin are predicted to have superhelical structures with ARM-type repeats
Bangalore K Sathyanarayana et al. BMC Struct Biol. 2009.
Abstract
Background: Mesothelin is a 40 kDa protein present on the surface of normal mesothelial cells and overexpressed in many human tumours, including mesothelioma and ovarian and pancreatic adenocarcinoma. It forms a strong and specific complex with MUC16, which is also highly expressed on the surface of mesothelioma and ovarian cancer cells. This binding has been suggested to be the basis of ovarian cancer metastasis. Knowledge of the structure of this protein will be useful, for example, in building a structural model of the MUC16-mesothelin complex. Mesothelin is produced as a precursor, which is cleaved by furin to produce the N-terminal half, which is called the megakaryocyte potentiating factor (MPF), and the C-terminal half, which is mesothelin. Little is known about the function of mesothelin and there is no information on its possible three-dimensional structure. Mesothelin has been reported to be homologous to the deafness-related inner ear proteins otoancorin and stereocilin, for neither of which the three-dimensional structure is known.
Results: The BLAST and PSI-BLAST searches confirmed that mesothelin and mesothelin precursor proteins are remotely homologous to stereocilin and otoancorin and more closely homologous to the hypothetical protein MPFL (MPF-like). Secondary structure prediction servers predicted a predominantly helical structure for both mesothelin and mesothelin precursor proteins and also for stereocilin and otoancorin. Three-dimensional structure prediction servers INHUB and I-TASSER produced structural models for mesothelin, which consisted of superhelical structures with ARM-type repeats in conformity with the secondary structure predictions. Similar ARM-type superhelical repeat structures were predicted by 3D-PSSM server for mesothelin precursor and for stereocilin and otoancorin proteins.
Conclusion: The mesothelin superfamily of proteins, which includes mesothelin, mesothelin precursor, megakaryocyte potentiating factor, MPFL, stereocilin and otoancorin, are predicted to have superhelical structures with ARM-type repeats. We suggest that all of these function as superhelical lectins to bind the carbohydrate moieties of extracellular glycoproteins.
Figures
Figure 1
Amino acid sequence and predicted secondary structure for human mesothelin. The first line gives the residue serial numbers and the second the sequence. The mature mesothelin sequence starts from the residue number 1, after the furin cleavage at the ARG-ARG (rr) sequence of the precursor. The signalling sequence for the GPI attachment that was suggested in an earlier study [1] is shown in low-case italics; the signalling sequence predicted using a current prediction program [45] is colored green. The 9 lines that follow give the predicted secondary structural type for each residue. The names of the programs are indicated at the right-hand side. The blue color indicates residues that were predicted to be helical unanimously by all programs. The magenta indicates all other helical predictions. The last line gives the secondary structures of model#1 of the I-TASSER server, calculated using the DSSP program (H: Helix, program output states H, h, G; E: Beta, E; C: Coil, all other output states). The helical residues in this model are colored green. The vertical lines indicate the boundaries of the 8 repeats of model#1 of the I-TASSER server.
Figure 2
Multiple alignments of the 10 repeats of 1BK5A (1bk5-1 to 1bk5-10) and the 8 repeats of mesothelin model (msln-1 to msln-8). The three double-headed arrows at the top of the Figure indicate the boundaries of the three helical regions of the 7th repeat of 1BK5A. The first two form the outer helices and the third the inner helix. The helix boundaries of other repeats do not always agree with those of the 1BK5A 7th repeat. The residues in the 7th repeat of 1BK5A are shown in the next line in uppercase letters. The residues in all other repeats that follow are in upper or lower case letters depending on whether they align with residues of the 7th repeat of 1BK5A or not, respectively. The columns labelled 10, 13, 16 and 17 at the bottom are the key positions in the outer helix that are hydrophobic in many ARM/HEAT repeats [40]. Similarly LxxxAxxxL at the bottom indicates the conserved LEU and ALA positions in the inner helix, x being any residue. The hydrophobic residues (A, V, I, L, M, F, Y, W) in these 7 columns are highlighted.
Figure 3
Stereo pair of the ribbon representation of the 3D structure of model #1 from I-TASSER server. The chain runs N-terminal to C-terminal from bottom to top in the figure. Repeats 1, 3, 5, and 7 are in orange; repeats 2, 4, 6, and 8 are in yellow; the residues highlighted in Figure 2 are in green. The drawing was made using Chimera
[53].
Figure 4
A phylogenetic tree of mesothelin precursor and related proteins. The unrooted tree was made using the Neighbor-Joining method [54] implemented in the MEGA3 program [55]. The tree is based on a multiple alignment from the MUSCLE program of the conserved regions of selected mesothelin, MPFL, stereocilin, and otoancorin proteins (see additional file 1 for the alignment). The number 0.2 on the scale bar indicates the number of substitutions per site.
Similar articles
- Otoancorin, an inner ear protein restricted to the interface between the apical surface of sensory epithelia and their overlying acellular gels, is defective in autosomal recessive deafness DFNB22.
Zwaenepoel I, Mustapha M, Leibovici M, Verpy E, Goodyear R, Liu XZ, Nouaille S, Nance WE, Kanaan M, Avraham KB, Tekaia F, Loiselet J, Lathrop M, Richardson G, Petit C. Zwaenepoel I, et al. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6240-5. doi: 10.1073/pnas.082515999. Epub 2002 Apr 23. Proc Natl Acad Sci U S A. 2002. PMID: 11972037 Free PMC article. - Sequence similarity between stereocilin and otoancorin points to a unified mechanism for mechanotransduction in the mammalian inner ear.
Jovine L, Park J, Wassarman PM. Jovine L, et al. BMC Cell Biol. 2002 Nov 25;3:28. doi: 10.1186/1471-2121-3-28. Epub 2002 Nov 25. BMC Cell Biol. 2002. PMID: 12445334 Free PMC article. - Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.
Scholler N, Fu N, Yang Y, Ye Z, Goodman GE, Hellström KE, Hellström I. Scholler N, et al. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11531-6. doi: 10.1073/pnas.96.20.11531. Proc Natl Acad Sci U S A. 1999. PMID: 10500211 Free PMC article. - Mesothelin: a new target for immunotherapy.
Hassan R, Bera T, Pastan I. Hassan R, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3937-42. doi: 10.1158/1078-0432.CCR-03-0801. Clin Cancer Res. 2004. PMID: 15217923 Review. - Clinical impacts of mesothelin expression in gastrointestinal carcinomas.
Einama T, Kawamata F, Kamachi H, Nishihara H, Homma S, Matsuzawa F, Mizukami T, Konishi Y, Tahara M, Kamiyama T, Hino O, Taketomi A, Todo S. Einama T, et al. World J Gastrointest Pathophysiol. 2016 May 15;7(2):218-22. doi: 10.4291/wjgp.v7.i2.218. World J Gastrointest Pathophysiol. 2016. PMID: 27190694 Free PMC article. Review.
Cited by
- Metastasis of cervical cancer indicated by elevation of serum CA125 produced by mediastinal lymph nodes: a case report.
Honda KI, Miyama M, Nishii Y, Tasaka R, Nakano Y, Umesaki N, Fukuda T, Ichimura T, Yasui T, Sumi T. Honda KI, et al. J Med Case Rep. 2024 Feb 25;18(1):112. doi: 10.1186/s13256-024-04417-2. J Med Case Rep. 2024. PMID: 38402387 Free PMC article. - Biology of Mesothelin and Clinical Implications: A Review of Existing Literature.
Hagerty BL, Takabe K. Hagerty BL, et al. World J Oncol. 2023 Oct;14(5):340-349. doi: 10.14740/wjon1655. Epub 2023 Sep 20. World J Oncol. 2023. PMID: 37869242 Free PMC article. Review. - RNAseq profiling of blood from patients with coronary artery disease: Signature of a T cell imbalance.
McCaffrey TA, Toma I, Yang Z, Katz R, Reiner J, Mazhari R, Shah P, Falk Z, Wargowsky R, Goldman J, Jones D, Shtokalo D, Antonets D, Jepson T, Fetisova A, Jaatinen K, Ree N, Ri M. McCaffrey TA, et al. J Mol Cell Cardiol Plus. 2023 Jun;4:100033. doi: 10.1016/j.jmccpl.2023.100033. Epub 2023 Mar 25. J Mol Cell Cardiol Plus. 2023. PMID: 37303712 Free PMC article. - Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic Antibodies.
Zhan J, Lin D, Watson N, Esser L, Tang WK, Zhang A, Liu X, Hassan R, Gleinich A, Shajahan A, Azadi P, Pastan I, Xia D. Zhan J, et al. Cancer Res Commun. 2023 Feb 1;3(2):175-191. doi: 10.1158/2767-9764.CRC-22-0306. eCollection 2023 Feb. Cancer Res Commun. 2023. PMID: 36968141 Free PMC article. - Mesothelin: An Immunotherapeutic Target beyond Solid Tumors.
Faust JR, Hamill D, Kolb EA, Gopalakrishnapillai A, Barwe SP. Faust JR, et al. Cancers (Basel). 2022 Mar 18;14(6):1550. doi: 10.3390/cancers14061550. Cancers (Basel). 2022. PMID: 35326701 Free PMC article. Review.
References
- Yamaguchi N, Hattori K, Oh-eda M, Kojima T, Imai N, Ochi N. A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5. J Biol Chem. 1994;269:805–808. - PubMed
- Yamaguchi N, Yamamura Y, Konishi E, Ueda K, Kojima T, Hattori K, Oheda M, Imai N, Taniguchi Y, Tamura M, et al. Characterization, molecular cloning and expression of megakaryocyte potentiating factor. Stem Cells. 1996;14:62–74. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous